She is a member of the Health Sciences Department, where her practice focuses on the defense of pharmaceutical companies in civil litigation and regulatory counseling. Her practice includes extensive expert witness work and analysis of medical literature. She counsels pharmaceutical companies on adverse event reporting and analysis, and on regulatory submissions and responses to inquiries from regulatory authorities.